返回
Fetal reduction for everyone?
DOI:10.1016/j.bpobgyn.2022.04.003.png)
摘要
En 中文
Infertility treatments have benefited millions of couples to have their own children; however, the complication of multiple pregnancies with their increased morbidity and mortality has created significant problems. Fetal reduction (FR) was developed to ameliorate these issues. Over 30 years of publications show that FR has been highly successful in substantially reducing both mortality and morbidity. As with most radically new techniques, initial cases were in the nothing to lose category. With experience, indications liberalize, and quality of life issues increase as a proportion of cases. Overall risks for twins are not twice as those for singletons, but they are approximately 4- to 5-fold higher. In experienced hands, the combination of genetic testing by CVS followed by FR has made most multiples behave statistically as if they were originally the lower number. The use of microarray analysis to better determine fetal genetic health before deciding on which fetus(es) to keep or reduce further improves pediatric outcomes. With increasing experience and lower average starting numbers, the proportion of FRs to a singleton has increased considerably. Twins to a singleton FR now constitute an increasing proportion of cases performed. Data on such cases show improved outcomes, and we believe FR should be at least discussed and offered to all patients with a dichorionic twin pregnancy or higher. eSET is not a panacea because of the resultant monochorionic twins. (c) 2022 Published by Elsevier Ltd.
Keyword:
Multiple pregnancy
Twins
Fetal reduction
CVS
Amniocentesis
Cerebral palsy
期刊
B
IF:
4.1
论文数:
2.0K
被引数:
6.2K
机构
引用论文
Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network来自NICHD新生儿研究网络的极早产儿的新生儿结局
PEDIATRICS
IF6.4

